Legend Biotech shareholders voted at annual general meeting
Bitget2026/09/24 20:00- Legend Biotech held its annual general meeting on Sept. 24, 2026.
- Shareholders received the audited consolidated financial statements for the year ended Dec. 31, 2025.
- Ernst & Young LLP was ratified as independent auditor for the fiscal year ending Dec. 31, 2026.
- Robin Meng, Corazon D. Sanders, Li Mao, Peter Salovey were re-elected as Class III directors for three-year terms.
- Share plan amendment was adopted to add 19.1 million ordinary shares; directors and officers were authorized to implement resolutions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote
Crypto prices
More
